As the Senior Director for Emerging Markets at Citeline, a Norstella Company, Poorna Chandra Tejasvik plays a pivotal role in shaping the strategic direction and growth of the organization within the dynamic landscape of the pharmaceutical and biotech sectors. With over 20 years of extensive...
As the Senior Director for Emerging Markets at Citeline, a Norstella Company, Poorna Chandra Tejasvik plays a pivotal role in shaping the strategic direction and growth of the organization within the dynamic landscape of the pharmaceutical and biotech sectors. With over 20 years of extensive experience in the life sciences industry, Poorna leverages his deep expertise in consultative selling and business development to drive revenue growth and expand Citeline's footprint in India and other emerging markets. His responsibilities encompass identifying new opportunities, fostering client relationships, and delivering tailored solutions that address the unique challenges faced by health science professionals.
Under Poorna's leadership, Citeline has launched several key projects aimed at enhancing its market-leading data, insights, analytics, and consulting solutions. These initiatives not only focus on improving the efficiency of clinical trials and regulatory affairs but also emphasize the importance of patient-centric approaches in drug development. Poorna's ability to navigate the complexities of the industry, combined with his strong skills in team management and discovery processes, positions him as a trusted advisor to clients seeking to optimize their strategies in an increasingly competitive environment.
Moreover, Poorna's MBA in Marketing complements his technical knowledge, enabling him to effectively communicate the value of Citeline's offerings to stakeholders across the pharmaceutical and biotech landscape. His commitment to innovation and excellence ensures that Citeline remains at the forefront of industry trends, empowering clients with actionable insights that drive informed decision-making and ultimately improve patient outcomes.
